External preparation of neurokinin 1 receptor inhibitor and preparation method of external preparation
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHANGSHA JINGYI PHARM TECH CO LTD
- Publication Date
- 2021-08-20
Smart Images

Figure 1
Abstract
Description
technical field
[0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a series of external preparations of NK1 receptor inhibitors and a preparation method thereof. Background technique
[0002] At present, the main treatment methods for cancer include surgery, chemotherapy and radiotherapy, but many adverse reactions are often caused during the treatment process, such as wound pain after surgery, and chemotherapy with cisplatin and other drugs can cause nausea, vomiting, dermatitis, hair loss, etc., which greatly increase the risk of cancer. Physical and psychological pain of the patient.
[0003] Chemotherapy-induced nausea and vomiting (CINV) is the most common adverse reaction during cancer treatment, and about 70% to 80% of patients will experience this symptom. Severe nausea and vomiting not only lead to nutritional deficiencies, Dehydration and electrolyte imbalance can also force patients to discontinue effe...